🇺🇸 FDA
Pipeline program

Fenofibrate

KY20151230-5

Phase 3 small_molecule active

Quick answer

Fenofibrate for Primary Biliary Cirrhosis is a Phase 3 program (small_molecule) at Xijing Hospital of Digestive Diseases with 1 ClinicalTrials.gov record(s).

Program details

Company
Xijing Hospital of Digestive Diseases
Indication
Primary Biliary Cirrhosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials